Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
Sanofi Winthrop Industrie Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Paris, March 31, 20…
#France #FR #Europe #EU #Sanofi #chronicGVHD #clinicalstudies #EuropeanMedicinesAgency #graft-versus-hostdisease #marketingauthorisation #ROCKstar #SorbonneUniversity #stemcelltransplant #systemictherapy #TheEuropeanCommission #treatmentoptions
https://www.europesays.com/france/19451/